| Literature DB >> 36185148 |
Plaipol Dedvisitsakul1,2, Kanchana Watla-Iad1,3.
Abstract
Diabetes mellitus is the most common non-infective disease characterized by hyperglycemia (high level of blood glucose). Formation of advanced glycation end products (AGEs) in long termed-hyperglycemia and oxidative stress are the key factors to accelerate diabetic complications. To screen potential candidates for treating diabetes, total phenolic content, total flavonoid content, antioxidant activity from crude extracts of some Thai edible plants were primarily assessed, and the inhibiting potential of diabetes and its complications provided from some of these plants were evaluated in terms of their inhibitory activities of α-amylase, α-glycosidase, and AGEs formation. The highest amounts of phenolic and flavonoid compounds were found in the ethanolic extract of Caesalpinia mimosoides (S20, 12.63 ± 1.70 mg GAE/g DW) and Glochidion hirsutum (S8, 3.02 ± 0.25 mg CE/g DW), respectively. The highest antioxidant activity was found in Schinus terebinthifolius Raddi (S26, 217.94 ± 32.30 μg AAE/g DW) whereas the highest inhibitory activities of α-amylase and α-glycosidase were obtained from Basella alba L. (S11, IC50 = 0.21 ± 0.01 mg/ml) and S. terebinthifolius (S26, IC50 = 0.05 ± 0.02 mg/ml) respectively. The inhibitory effects of AGEs formation were studied in vitro using two model systems: BSA-glucose and BSA-methylglycoxal (MGO). The extracts of Glochidion hirsutum (Roxb.) Voigt (S8, IC50 = 0.20 ± 0.01 mg/ml) and Polygonum odoratum Lour. (S13, IC50 = 0.03 ± 0.01 mg/ml) exhibited the inhibitory activity of AGEs formation derived from glucose (BSA-glucose system) stronger than aminoguanidine (AG) (0.26 ± 0.00 mg/ml), which is a common AGEs formation inhibitory drug. By BSA-MGO assay, the inhibition of some selected extracts in this study (G. hirsutum, G. sphaerogynum, and S. terebinthifolius with IC50 = 0.11 ± 0.01, 0.11 ± 0.01, and 0.10 ± 0.00 mg/ml, respectively) were slightly less efficient than AG (the IC50 = 0.06 ± 0.00 mg/ml). These results indicated that some selected Thai edible plants in this present study provided potential applications towards the prevention of diabetes and their complications via the inhibitory of α-amylase, α-glycosidase, AGEs formation, and oxidative stress. This fundamental information would be important for alternative drug discovery and nutritional recommendations for diabetic patients.Entities:
Keywords: Anti-diabetes; Antiglycation; Antioxidant activity; Indigenous edible plants in Northern Thailand; α-Amylase inhibition; α-Glucosidase inhibition
Year: 2022 PMID: 36185148 PMCID: PMC9519484 DOI: 10.1016/j.heliyon.2022.e10740
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Information of Thai indigenous edible plants collected from Northern Thailand used in this study.
| Local Name (Sample code) | Scientific names (Family names) | Medicinal properties | Traditional uses |
|---|---|---|---|
| Kan Aor (S1) | Hepatoprotective, anti-inflammatory, immune enhancement, hypoglycemic ( | Food and medicinal ( | |
| Khao Tong (S2) | anti-mutagenic, anti-cancer, anti-obesity, anti-viral, anti-bacterial, anti-inflammatory, anti-microbial, anti-allergic, antioxidant and anti-diabetic ( | Vegetable and aromatic medicinal herb ( | |
| Chiang Da (S3) | Anti-diabetic, gout, rheumatoid arthritis ( | Vegetable and herb tea products ( | |
| Bon Tao (S4) | Antioxidant ( | Food supplement, religious ceremonies, and ornamental plant ( | |
| Bai Ma Pin (S5) | Antidiarrheal, anti-microbial, anti-inflammatory, antipyretic, and anti-diabetic ( | Fruits and vegetables ( | |
| Bai Mamao (S6) | Antibacterial ( | Medicinal purposes and food product ( | |
| Paem (S7) | Anti-tumor, rheumatism, anti-inflammatory, arthritis and hypertension ( | Folk medicine, and herbal tea ( | |
| Phak Khi Mot (S8) | Leaf: toothaches, carbuncles, urticaria, eczema ( | Folk medicine ( | |
| Phak Khi Kuang (S9) | analgesic, antidiabetic, anti-hyperlipidemic, antihelminthic, antidiarrhoeal, diuretic, | Traditional medicine ( | |
| Phak Chum Pa (S10) | Treat gastrointestinal disorders ( | Folk medicine ( | |
| Phak Pang (S11) | Hypoglycemic potential, and antidiabetic action ( | Vegetable ( | |
| Phak Phet (S12) | Anti-inflammatory ( | Food flavoring and folk medicine ( | |
| Phak Phai (S13) | Antioxidant activities ( | Herb, aromatic plants ( | |
| Phak Man Pla (S14) | Anti-cancer (breast adenocarcinoma, cell lung cancer and central nervous system tumors) ( | Food and medicinal purposes ( | |
| Phak Yira (S15) | Anti-inflammatory, anti-cancer, treating diarrhea, anti-diabetic ( | Medicinal purposes ( | |
| Phak Siao (S16) | Antipsychotic, analgesic activities, antiulcer activity ( | Folk medicine ( | |
| Phak Hom/Khom Mueang (S17) | Antioxidant, antipyretic ( | Folk medicine and juice ( | |
| Phak Hak (S18) | Antioxidant activity ( | Edible wild vegetable ( | |
| Phak Hudt (S19) | Treat diabetes ( | Traditional medical practices ( | |
| Phi Puya (S20) | Antimicrobial, antioxidant ( | Folk medicine ( | |
| Phaya Yo (S21) | Antivenom, analgesic, anti-inflammatory, immunomodulating, neuromodulating, anti-diabetic, antioxidant, anti-cancer ( | Traditional herb and vegetable ( | |
| Phia Phan (S22) | Wound healing, antioxidant ( | Folk medicine ( | |
| Yot Nang Laew (S23) | - | Relieves back and waist pains ( | |
| Yanang (S24) | Anti-diabetes ( | Food ( | |
| Luk Chi Kuk (S25) | Antiulcerogenic effects, hepatoprotective activity, and fungi toxicant ( | Food and medicine ( | |
| Sa Riam Malay (S26) | Microbiological quality, antioxidant activity, activity of α-glucosidase inhibitory and anti-glycation ( | Traditional medicine ( | |
| Hom Yae (S27) | Analgesic, antibacterial, anti-cancer, anti-convulsant, anti-fungal, anti-inflammatory and antioxidant ( | Herb, ingredient and flavoring in food ( | |
| Huan Moo (S28) | Anti-diabetic, antioxidant, anti-diabetes, antibacterial ( | Ingredient in medicine ( |
Results of the total phenolic and flavonoid contents, the antioxidant activity, α-amylase inhibition, and α-glucosidase inhibition activities of the indigenous edible plants (S1–S28).
| Sample Code | TPC content (mg GAE/g DW) | TFC content (mg CE/g DW) | Antioxidant activity (μg AAE/g DW) | α-Amylase inhibition (IC50 mg/ml) | α-Glucosidase inhibition (IC50 mg/ml) |
|---|---|---|---|---|---|
| S1 | 0.80 ± 0.10 | 0.81 ± 0.07 | 3.36 ± 0.34 | 1.01 ± 0.02 | 3.01 ± 0.35 |
| S2 | 1.53 ± 0.18 | 2.15 ± 0.11 | 5.23 ± 0.45 | 1.79 ± 0.08 | 2.43 ± 0.30 |
| S3 | 1.92 ± 0.21 | 2.13 ± 0.24 | 2.76 ± 0.40 | 1.41 ± 0.02 | 2.28 ± 0.23 |
| S4 | 0.25 ± 0.03 | 0.40 ± 0.00 | 1.14 ± 0.04 | 2.73 ± 0.12 | 8.72 ± 0.95 |
| S5 | 2.45 ± 0.29 | 1.18 ± 0.17 | 3.84 ± 0.36 | 1.21 ± 0.01 | 18.25 ± 1.39 |
| S6 | 3.40 ± 0.39 | 2.82 ± 0.23 | 10.01 ± 0.72 | 1.63 ± 0.44 | 4.67 ± 0.44 |
| S7 | 0.65 ± 0.06 | 0.60 ± 0.06 | 0.93 ± 0.09 | 2.89 ± 0.21 | 4.64 ± 0.53 |
| S8 | 11.57 ± 1.16 | 181.74 ± 17.28 | 1.01 ± 0.02 | 0.59 ± 0.08 | |
| S9 | 0.44 ± 0.05 | 0.81 ± 0.10 | 1.30 ± 0.17 | 2.31 ± 0.05 | 9.14 ± 1.04 |
| S10 | 0.80 ± 0.10 | 0.99 ± 0.11 | 0.92 ± 0.07 | 0.85 ± 0.02 | 5.80 ± 0.53 |
| S11 | 0.94 ± 0.09 | 0.75 ± 0.08 | 1.12 ± 0.06 | 2.05 ± 0.22 | |
| S12 | 0.42 ± 0.05 | 1.11 ± 0.01 | 1.84 ± 0.03 | 1.47 ± 0.01 | 6.53 ± 0.76 |
| S13 | 3.89 ± 0.45 | 2.93 ± 0.02 | 30.52 ± 2.68 | 1.93 ± 0.01 | 0.66 ± 0.08 |
| S14 | 4.83 ± 0.51 | 1.93 ± 0.02 | 42.19 ± 1.64 | 2.21 ± 0.07 | 2.84 ± 0.00 |
| S15 | 1.24 ± 0.10 | 0.77 ± 0.00 | 3.24 ± 0.11 | 1.73 ± 0.19 | 7.93 ± 0.74 |
| S16 | 0.29 ± 0.01 | 0.74 ± 0.01 | 0.35 ± 0.00 | 1.48 ± 0.00 | 1.81 ± 0.21 |
| S17 | 0.40 ± 0.05 | 0.92 ± 0.02 | 2.61 ± 0.22 | 0.49 ± 0.05 | 3.74 ± 0.03 |
| S18 | 0.38 ± 0.03 | 0.68 ± 0.01 | 2.72 ± 0.00 | 2.28 ± 0.01 | 2.97 ± 0.03 |
| S19 | 0.46 ± 0.01 | 1.12 ± 0.04 | 0.94 ± 0.05 | 1.47 ± 0.02 | 6.12 ± 0.70 |
| S20 | 1.20 ± 0.11 | 5.16 ± 0.66 | 1.15 ± 0.06 | 0.18 ± 0.03 | |
| S21 | 0.59 ± 0.05 | 1.07 ± 0.02 | 0.96 ± 0.08 | 1.98 ± 0.05 | 7.52 ± 0.49 |
| S22 | 1.90 ± 0.18 | 1.67 ± 0.14 | 1.67 ± 0.19 | 3.03 ± 0.06 | 1.25 ± 0.27 |
| S23 | 0.63 ± 0.07 | 1.04 ± 0.04 | 2.24 ± 0.00 | 0.50 ± 0.02 | 6.02 ± 0.08 |
| S24 | 0.59 ± 0.07 | 0.47 ± 0.02 | 1.54 ± 0.10 | 1.39 ± 0.02 | 3.09 ± 0.38 |
| S25 | 0.43 ± 0.06 | 2.38 ± 0.13 | 3.80 ± 0.56 | 0.92 ± 0.02 | 1.12 ± 0.15 |
| S26 | 10.84 ± 1.86 | 1.64 ± 0.04 | 1.29 ± 0.02 | ||
| S27 | 0.76 ± 0.10 | 1.07 ± 0.10 | 0.00 ± 0.00 | 0.34 ± 0.01 | 2.70 ± 0.30 |
| S28 | 2.98 ± 0.36 | 1.80 ± 0.09 | 10.34 ± 0.17 | 0.90 ± 0.01 | 1.69 ± 0.14 |
TPC: Total phenolic content; TFC: Total flavonoid content; the IC50 for α-glucosidase and α-amylase inhibition activities of acarbose were 1.59 ± 0.08 mg/ml and 0.29 ± 0.02 mg/ml, respectively.
Figure 1Anti-AGEs formation activity of the selected plant extracts at different concentrations in BSA-glucose model (A), and in BSA-MGO model (B). Aminoguanidine (AG) was used as a positive control.
Figure 2Comparison of the concentrations of crude plant extract at 50% inhibition (IC50) of fluorescent advanced glycation end products (AGEs) formation in BSA-glucose model (A), and in BSA-MGO model (B). Aminoguanidine (AG) was used as a positive control.
The precursor, target products, and some confirmation products with associated collision energies and their retention time of the phenolic compounds.
| Compounds | Molecular formula | IM∗ | Precursor (m/z) | Products (m/z) | RT | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QT | Q1 | CE (eV) | Q3 | CT | Q1 | CE (eV) | Q3 | |||||
| Caffeic acid | C9H8O4 | ESI- | 178.8 | 135.20 | 19 | 18 | 12 | - | - | - | - | 6.638 |
| Gallic acid | C7H6O5 | ESI- | 169.1 | 125.20 | 12 | 17 | 12 | - | - | - | - | 2.221 |
| Chlorogenic acid | C16H18O9 | ESI- | 352.95 | 191.05 | 17 | 20 | 11 | - | - | - | - | 3.277 |
| C9H8O3 | ESI- | 162.85 | 119.00 | 17 | 15 | 17 | - | - | - | - | 9.353 | |
| C9H8O3 | ESI- | 163.0 | 119.00 | 18 | 15 | 23 | - | - | - | - | 11.553 | |
| Catechin | C15H14O6 | ESI- | 289.25 | 245.20 | 15 | 15 | 15 | 205.20 | 11 | 17 | 13 | 5.173 |
| Ferulic acid | C10H10O4 | ESI- | 193.0 | 134.10 | 10 | 15 | 13 | 178.05 | 21 | 15 | 16 | 10.317 |
| Quercetin | C15H10O7 | ESI- | 300.75 | 151.20 | 15 | 22 | 13 | 179.00 | 15 | 20 | 17 | 12.102 |
Remark: RT: retention time; IM: ionization mode; QT: quantification transition mass (target mass); CT: confirmation transition mass.
Phytochemical compound contents found in the crude extracts of the studied indigenous edible plants.
| Sample Code | Phytochemical compound contents (μg/g dried crude extract) | |||||||
|---|---|---|---|---|---|---|---|---|
| CA (ug/g) | CGA | GA ug/g | PCA | C | PTC | Q | FA | |
| S1 | 845.30 ± 38.04 | 191.90 ± 8.64 | 8.90 ± 0.40 | 102.10 ± 4.59 | ND | 188.70 ± 8.49 | 1140.00 ± 39.90 | 116.30 ± 4.59 |
| S2 | 572.40 ± 24.61 | 2723.60 ± 62.64 | 17.40 ± 0.75 | 101.20 ± 4.35 | ND | 229.40 ± 9.18 | 563.70 ± 19.73 | 111.60 ± 4.41 |
| S3 | 17.20 ± 1.03 | 95.20 ± 5.71 | 1.00 ± 0.06 | 64.90 ± 2.92 | ND | |||
| S4 | 20.90 ± 1.25 | 137.80 ± 8.27 | ND | 8.70 ± 0.52 | ND | 53.10 ± 2.39 | ND | 26.70 ± 1.05 |
| S5 | 43.10 ± 2.59 | 125.70 ± 7.54 | 0.70 ± 0.04 | 165.70 ± 9.94 | 97.30 ± 5.84 | 69.90 ± 3.15 | ND | 48.70 ± 1.92 |
| S6 | 89.60 ± 3.14 | 9.60 ± 0.34 | 1560.20 ± 54.61 | ND | 193.30 ± 7.73 | 253.20 ± 8.86 | 127.30 ± 5.03 | |
| S7 | 472.50 ± 28.35 | 304.70 ± 18.28 | 11.80 ± 0.71 | 70.50 ± 4.23 | ND | 59.20 ± 2.66 | ND | 43.50 ± 1.72 |
| S8 | 41.40 ± 2.48 | 88.60 ± 5.32 | 10757.10 ± 225.90 | 233.90 ± 14.03 | ND | 115.40 ± 5.19 | ND | 28.90 ± 1.14 |
| S9 | 13.80 ± 0.83 | 88.30 ± 5.30 | 10.50 ± 0.63 | 18.40 ± 1.10 | 64.10 ± 3.85 | ND | ND | 17.70 ± 0.70 |
| S10 | 168.10 ± 10.09 | 109.40 ± 6.56 | 10.30 ± 0.62 | 69.60 ± 4.18 | ND | 48.80 ± 2.20 | ND | 25.90 ± 1.02 |
| S11 | 20.90 ± 1.25 | 115.20 ± 6.91 | ND | 16.20 ± 0.97 | ND | 44.30 ± 1.99 | ND | 54.90 ± 2.17 |
| S12 | 61.20 ± 3.67 | 105.50 ± 6.33 | 5.10 ± 0.31 | 67.10 ± 4.03 | 39.40 ± 2.36 | 50.00 ± 2.25 | ND | 185.50 ± 7.33 |
| S13 | 164.90 ± 9.89 | 183.10 ± 10.99 | 1241.50 ± 74.49 | 300.80 ± 12.03 | 44.20 ± 2.19 | 274.80 ± 9.62 | 2221.10 ± 51.09 | 144.20 ± 5.70 |
| S14 | 436.20 ± 18.89 | 304.40 ± 13.18 | 6641.90 ± 86.34 | 190.60 ± 8.25 | ND | 351.70 ± 12.31 | 16.60 ± 0.58 | 35.60 ± 1.41 |
| S15 | 1285.20 ± 64.26 | 100.70 ± 5.04 | 48.40 ± 2.42 | 116.50 ± 5.83 | ND | 164.20 ± 7.39 | ND | 119.90 ± 4.74 |
| S16 | 55.50 ± 3.33 | 122.40 ± 7.34 | 38.50 ± 2.31 | 7.10 ± 0.43 | ND | 50.70 ± 2.28 | ND | 30.70 ± 1.21 |
| S17 | 17.10 ± 10.03 | 112.20 ± 6.73 | ND | 15.10 ± 0.91 | ND | 25.50 ± 1.15 | ND | 21.00 ± 0.83 |
| S18 | ND | 102.80 ± 6.17 | ND | 3.10 ± 0.19 | ND | 39.40 ± 1.77 | ND | 17.60 ± 0.70 |
| S19 | 266.90 ± 16.01 | 28.00 ± 1.68 | 39.50 ± 2.37 | ND | 785.20 ± 18.45 | ND | 22.90 ± 0.90 | |
| S20 | 1286.50 ± 37.31 | 1250.10 ± 36.25 | 251.40 ± 7.29 | ND | 666.30 ± 23.32 | ND | ||
| S21 | 34.30 ± 2.06 | 109.40 ± 6.56 | 8.40 ± 0.50 | 45.60 ± 2.74 | ND | 41.90 ± 1.89 | ND | 32.90 ± 1.30 |
| S22 | ND | ND | ND | 236.20 ± 14.17 | ND | 52.20 ± 2.35 | ND | ND |
| S23 | 46.10 ± 2.77 | 107.40 ± 6.44 | 3.20 ± 0.19 | 452.20 ± 19.04 | ND | 43.50 ± 1.96 | ND | 303.00 ± 11.97 |
| S24 | 17.30 ± 1.04 | 127.50 ± 7.65 | 0.60 ± 0.04 | 23.70 ± 1.42 | ND | 45.40 ± 2.04 | ND | 25.30 ± 1.00 |
| S25 | ND | ND | ND | 22.30 ± 1.34 | ND | 0.00 ± 0.00 | ND | 22.40 ± 0.88 |
| S26 | 60.60 ± 3.64 | 125.10 ± 7.51 | 20587.30 ± 555.86 | 85.10 ± 5.11 | ND | 580.70 ± 16.48 | 32.90 ± 1.15 | ND |
| S27 | 223.60 ± 8.94 | 112.80 ± 4.51 | 13.00 ± 0.52 | 252.80 ± 5.84 | ND | 202.10 ± 9.09 | 31.30 ± 1.10 | 156.00 ± 6.16 |
| S28 | 129.00 ± 5.16 | 105.00 ± 4.20 | 44.00 ± 1.76 | 192.90 ± 7.72 | ND | 604.30 ± 24.17 | 333.80 ± 13.35 | |
CA: caffeic acid; GA: gallic acid; CGA: chlorogenic acid; PCA: p-coumaric acid; OCA: o-coumaric acid; C: catechin; FA: ferulic acid; PTC: protocatechuic acid; Q: quercetin; ND: not detectable.